Responsive image

SLAS2015 Short Courses

3D Cell-based Assays for Drug De-risking

The continually rising numbers of compound failures and increasing costs of drug and substance development are fostering the use of biologically more complex cell models. Physiological relevance is a key parameter to improve the predictive power of cell-based assays. The course covers advanced 3D cell culture technologies and their use in substance testing.

Who Should Attend:

Industry and academic scientists with mid- to advanced-level experience in cell-based assays or cell biology wishing to get a concise overview about technologies, advantages, cost and application examples of 3D cell-based assays.

How You Will Benefit From This Course:

Course Topics:

Instructors:

Prof. Dr. Ursula Graf-Hausner, University of Applied Sciences Zurich, Switzerland (3D cell and tissue culture technology, skin model applications): one of the most experienced academics in Switzerland in the field of 3D tissue engineering for compound testing, director of the Swiss competence center for "Tissue Engineering for Drug Development TEDD".

Dr. Jens M. Kelm, Chief scientific officer and co-founder of InSphero AG, Zurich, Switzerland (assays and applications in oncology and toxicology) and co-founder of the Swiss competence center for "Tissue Engineering for Drug Development TEDD": 14 years' experience in 3D cell culture using a wide variety of cells and technologies, previously director at the Center for Applied Biotechnology and Molecular Medicine at the University of Zurich CABMM.

Terry Riss
Promega Corporation (Guest Instructor)

Dr. Terry Riss started the Cell Biology program at Promega Corporation in 1990 and held several R&D and Project Management positions since. Dr. Riss managed development of cell viability, cytotoxicity, apoptosis, and protease assay systems and also lead efforts to identify and promote multiplexing of cell-based assays to determine the mechanism of cell death. Dr. Riss now serves as Senior Product Specialist, Cell Health involved in outreach educational training activities. Dr. Riss regularly participates in NIH study sections reviewing HTS grants and is co-editor of the cell culture assays section of the Assay Guidance Manual hosted by NIH.

Ty C. Voss
PerkinElmer, Inc. (Guest Instructor)

Dr. Ty C. Voss, Senior Applications Scientist within the Cellular Imaging and Analysis Team at PerkinElmer Inc.; formerly, the head of the High-Throughput Imaging Facility at the National Cancer Institute campus in Bethesda, MD: Dr. Voss has 18 years of experience in microscopy-based quantitative assay development and automated image analysis programming.